$SWRD

Stewards Inc. (SWRD) partners with Rain to develop a business card for small businesses, enabling flexible access to approved capital. The card, expected in Q1 2027, combines Stewards' financing platform with Rain's stablecoin-based payments infrastructure. Stewards handles underwriting, while Rain issues and manages the cards. The card aims to provide recurring access to capital, reducing friction for returning customers.

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. ENVY DEVELOPMENT PB, LLC CONSOLIDATED STATEMENT OF REVENUES AND CERTAIN EXPENSES For the Year Ended December 31, 2025 Table of Contents Page Independent Auditor’s Report 3 Consilidated Statement of Revenue and Certain Operating Expenses 5 Notes to the Consolidated Statement of Re

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. On September 21, 2026, Stewards, Inc. (the "Company") and Accretiv Investment Holdings Inc., a Georgia corporation (the "Lender"), entered into a Termination and Release Agreement, effective as of the same date (the "Termi

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On September 21, 2026, Stewards, Inc. (the “Company”) entered into Amendment No. 2 to Promissory Note (the “Amendment”), effective as of September 1, 2026, with FAVO Holdings, LLC (the “Holder”). The Amendment further amends th

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement As previously disclosed, on June 5, 2026, Stewards Real Estate, LLC ("Stewards Real Estate"), a wholly owned subsidiary of Stewards, Inc. (the "Company"), entered into a Purchase and Sale Agreement (the "Purchase Agreement"

Novo Nordisk (NVO) shares fell 4.8% to $41.15 in pre-market trading after Phase 3 trial results. Other stocks moving lower include Aligos Therapeutics (ALGS) down 15.1%, Telix Pharmaceuticals (TLX) down 7.9%, and Li Auto (LI) down 3.5%.

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 3.03 Material Modification to Rights of Security Holders. The information set forth under Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On Sep

Stewards received approval to list its common stock on Nasdaq under the symbol SWRD, with trading expected to begin on September 10, 2026. The company filed Form 8-A12B and will cease OTCID Market quotation on September 9, 2026. The listing does not involve a public offering, and the CUSIP remains 312084106.

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 3, 2026, Stewards, Inc. (the "Company") entered into Amendment No. 4 to Loan Agreement (the "Amendment") with Stewards International Funds PCC (on behalf of the Stewards Private Credit Fund) (the "Lender"). The Am

Stewards, Inc. (SWRD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 2, 2026, Stewards, Inc. (the “Company”) entered into a Promissory Note (the “Note”) and a related Security Agreement (the “Security Agreement”) with Accretiv Investment Holdings Inc. (the “Lender”) in connection w